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ABSTRACT
Background: The number of amphiregulin (AR)-positive mast cells in the bronchial mucosa and the levels of
AR in sputum from asthmatic patients have been reported to be increased. In addition, AR can promote mucin
gene expression in human epithelial cells, suggesting that AR contributes to the pathogenesis of allergic
asthma.
Methods: To elucidate the role of AR in the pathogenesis of asthma, we immunized AR-deficient mice with
ovalbumin (OVA) and then induced airway inflammation in them after OVA inhalation. The OVA-induced airway
inflammation was assessed on the basis of the lung histology, number of leukocytes in the bronchoalveolar lav-
age (BAL) fluid, Th2 cytokine levels in the BAL fluid and OVA-specific IgG1 and IgE levels in the serum and
compared between AR-sufficient and -deficient mice.
Results: The OVA-induced airway inflammation was comparable in the AR-sufficient and -deficient mice.
Conclusions: Amphiregulin is not essential for induction of acute airway inflammation by OVA in mice.
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INTRODUCTION
Allergic asthma is considered to be a typical Th2-type
cytokine-mediated chronic pulmonary disease.1,2 Th2-
cell-derived IL-4 and IL-13 are essential for IgE class-
switching and production by B cells. Subsequently,
IgE provokes antigen-specific mast cell activation to
induce degranulation and cytokine secretion, includ-
ing Th2-type cytokines such as IL-4 and IL-13.1,2 IL-5
and IL-13, and IL-9, are key cytokines for inducing ac-
cumulation and activation of eosinophils and mast
cells, respectively, in sites of inflammation.1,2 There-
fore, these Th2-type cytokines orchestrate the activa-
tion of various types of immune cells, leading to exac-
erbation of airway inflammation and airway hyperre-
sponsiveness. In particular, Th2 cells and mast cells,
as sources of Th2-type cytokines, are deeply involved
in the pathogenesis of asthma.
We previously demonstrated that human mast cells
can produce amphiregulin (AR), which is a member
of the EGF family of growth factorscytokines, after
IgE-FcεRI crosslinking.3 AR is known to be physio
pathologically involved in mammary gland develop-
ment, blastocyst implantation, bone formation and
nerve regeneration, and to contribute to the progres-
sion of breast cancer.4,5 In addition, AR can activate
keratinocytes and epidermal hyperplasia, suggesting
that it is involved in the pathogenesis of psoriasis.5,6
However, the precise contributions of AR to the im-
mune responses are poorly understood. Regarding
this, we reported for the first time that the number of
AR-expressing mast cells was increased in bronchial
mucosa from patients with asthma.3 Moreover, AR
promoted expression of the mucin gene such as
MUC2 and MUC5AC in human epithelial cells3 and
proliferation of human lung fibroblasts.7 In addition
to mast cells, it was shown that Th2 cells, but not Th1
cells, expressed AR, and that Th2-cell-derived AR en-
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hanced resistance to nematode infection.8 These ob-
servations suggest that AR produced by mast cells
andor Th2 cells potentially contributes to the devel-
opment of immune responses to infections and aller-
gies. In support of this notion, Kim et al.9 very re-
cently reported that the levels of AR in the sputum
from patients with asthma were increased and corre-
lated with an increased number of eosinophils in the
sputum. However, the precise role of AR in the patho-
genesis of asthma remains to be elucidated. There-
fore, in the present study, we used AR-deficient mice
to investigate the contribution of AR in the develop-
ment of allergen-induced airway inflammation.
METHODS
MICE
Amphiregulin-deficient (AR--) mice on a 129 × B6
mixed background were originally generated as de-
scribed elsewhere.10 Littermates (AR+- and AR--
mice) were used in all experiments. By ELISA, the
levels of AR in lung homogenates were comparable
between AR++ and AR+- mice (data not shown). The
mice were housed under specific pathogen-free con-
ditions at the National Research Institute for Child
Health and Development, and the animal protocols
were approved by the Institutional Review Board of
the National Research Institute for Child Health and
Development.
OVA-INDUCED AIRWAY INFLAMMATION
OVA-induced airway inflammation was established in
the mice as described elsewhere.11 Briefly, mice were
immunized intraperitoneally with 10 μg OVA (Grade
V, SIGMA-Aldrich, St Louis, MO, USA) in 0.2 ml PBS
on days 1, 3, 5, 7, 9, 11 and 13. On days 41, 44 and 47,
the animals were treated intranasally with 200 μg
OVA in 20 μl PBS or with 20 μl PBS alone.
HISTOLOGY
At 24 hours after the last OVA or PBS inhalation,
lungs were harvested and fixed in Carnoy’s fluid. The
fixed lungs were embedded in paraffin, and 5-μm-
thick serial sections were stained with hematoxylin
and eosin (H&E).
BAL FLUID
At 24 hours after the last OVA or PBS inhalation, BAL
fluid and cells were collected as described previ-
ously.12 The total cell number in the BAL fluids was
counted, and cytospin specimens were prepared to
quantify the proportions of the different cell types af-
ter staining with Hansel’s stain.
CYTOKINE ELISA
IL-4, IL-5, eotaxin, TSLP and AR levels in the BAL flu-
ids were measured using mouse IL-4 and IL-5 ELISA
kits (eBioscience, San Diego, CA, USA) and mouse
eotaxin, TSLP and amphiregulin and humanmouse
TGF-β1 ELISA kits (R&D Systems, Minneapolis, MN,
USA).
OVA-SPECIFIC Ig DETECTION
At 24 hours after the last OVA or PBS inhalation,
blood was collected, and the serum was separated
and stored at -80℃ until assay. OVA-specific IgG1
and IgE levels in sera were determined as described
elsewhere.13
STATISTICAL ANALYSES
Data show the mean + SEM and were evaluated for
statistical significance using the two-tailed Student’s t
test.
RESULTS
AMPHIREGULIN IS NOT ESSENTIAL FOR THE
DEVELOPMENT OF IgE- AND MAST CELL-
MEDIATED OVA-INDUCED AIRWAY INFLAMMA-
TION
It is known that the requirement for mast cells and
IgE in the development of mouse airway inflamma-
tion induced by OVA differs as a result of whether the
sensitization with OVA is performed in the presence
or absence of aluminum hydroxide (alum). That is,
mast cells and IgE are required for sensitization in
the absence of alum, but not in the presence of
alum.14 Since we reported that AR is produced by
mast cells after IgE-FcεRI crosslinking, we used AR-
deficient mice to investigate the role of AR in IgE-
and mast cell-mediated OVA-induced airway inflam-
mation. After OVA sensitization without alum, mice
were treated intranasally with OVA or PBS. At 24
hours after the last OVA challenge, the numbers of
total cells, eosinophils, macrophages, lymphocytes
and neutrophils in the BAL fluid were comparable be-
tween AR+- and AR-- mice (Fig. 1). Consistent with
those BAL cell profiles, airway inflammation such as
leukocyte recruitment, goblet and epithelial cell hy-
perplasia and mucus secretion assessed on the basis
of the lung histology was also similar in the AR+- and
AR-- mice after the OVA challenge (Fig. 2). These ob-
servations indicate that AR is not essential for IgE-
and mast cell-mediated OVA-induced airway inflam-
mation in mice.
AMPHIREGULIN-DEFICIENT MICE SHOWED
IDENTICAL LEVELS OF Th2 CYTOKINES IN BAL
FLUIDS DURING MURINE ASTHMA
We next examined the contribution of AR to the pro-
duction of Th2 cytokines such as IL-4, IL-5 and IL-13
and AR-receptor expressing epithelial cell-derived cy-
tokines such as eotaxin, TGF-β1 and TSLP during
IgE- and mast cell-mediated OVA-induced airway in-
flammation. At 24 hours after the last OVA inhalation,
the levels of IL-4 and eotaxin were significantly in-
creased in BAL fluid from OVA-challenged mice in
comparison with PBS-treated mice (Fig. 3). However,
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Fig. 1 Number of BAL cels in amphiregulin-deficient mice during OVA-in-
duced airway inflammation. OVA-sensitized mice were treated intranasaly 
with OVA or PBS alone. At 24 hours after the last OVA or PBS inhalation, 
BAL fluids were colected. Then the number and types of cels in the BAL 
fluids were determined. Open columns = AR+/- mice (PBS: n = 5; OVA: n = 
15), and closed columns = AR-/- mice (PBS: n = 5; OVA: n = 14). Data show 
the mean + SEM.
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Fig. 2 Airway inflammation was similarly observed in amphiregulin-deficient mice during OVA-induced airway 
inflammation. At 24 hours after the last OVA or PBS inhalation, lungs were harvested from mice as shown in Fig-
ure 1. The sections of lungs were stained with H & E. Scale bars = 100 μm. Data show a representative result.
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Fig. 3 IL-4 and eotaxin levels in BAL fluids from 
amphiregulin-deficient mice during OVA-induced airway 
inflammation. At 24 hours after the last OVA or PBS inhala-
tion, BAL fluids were colected from mice as shown in Figure 
1. IL-4 and eotaxin levels in the BAL fluids were determined 
by ELISA. Open columns = AR+/- mice (PBS: n = 5; OVA: 
n = 15), and closed columns = AR-/- mice (PBS: n = 5; OVA: 
n = 14). Data show the mean + SEM.
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Fig. 4 Serum OVA-specific IgG1 and IgE levels in 
amphiregulin-deficient mice during OVA-induced airway 
inflammation. At 24 hours after the last OVA or PBS inhala-
tion, sera were colected from mice as shown in Figure 1. 
OVA-specific IgG1 and IgE levels in the sera were deter-
mined by ELISA. Open columns = AR+/- mice (PBS: n = 5; 
OVA: n = 15), and closed columns = AR-/- mice (PBS: n = 5; 
OVA: n = 14). Data show the mean + SEM.
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the amounts of AR, IL-5, IL-13, TGF-β1 and TSLP in
the BAL fluids were below the limit of detection by
ELISA in the tested settings (data not shown). We
found that the levels of IL-4 and eotaxin in BAL fluids
were indistinguishable between the OVA-challenged
AR-- mice and the OVA-challenged AR+- mice (Fig.
3), indicating that AR is not necessary for IL-4 and eo-
taxin production during IgE- and mast cell-mediated
OVA-induced airway inflammation in mice.
OVA-SPECIFIC Ig PRODUCTION IS EQUIVA-
LENT IN AMPHIREGULIN-DEFICIENT MICE DUR-
ING MURINE ASTHMA
OVA-specific IgE is important for the pathogenesis of
the murine asthma model. At 24 hours after the last
OVA inhalation, the levels of OVA-specific IgG1 and
IgE were markedly increased in sera from OVA-
challenged mice compared with sera from PBS-
treated mice (Fig. 4). However, the Ig levels were not
statistically different between AR+- and AR-- mice
(Fig. 4). These observations indicate that AR is not
responsible for Th2-cytokine-dependent IgG1 and
IgE production during IgE- and mast cell-mediated
OVA-induced airway inflammation in mice.
DISCUSSION
Amphiregulin, a member of the EGF family of growth
factorscytokines, was first identified in supernatants
from breast cancer cell lines stimulated with PMA.15
AR has dual functions: it both enhances and inhibits
the growth of certain cell lines.4,5 In addition to its
role as a growth factor, AR also acts as a cytokine in
immune systems.8 Indeed, Th2-cell-derived AR is cru-
cial for host defense against nematode infection.8
Moreover, IgE-FcεRI-stimulated mast cells produce
AR, and AR enhances mucin gene expression in hu-
man epithelial cells and proliferation of human lung
fibroblasts.3,7 These observations suggest that AR
may contribute to the pathogenesis of Th2 cell- and
mast cell-mediated immune responses, such as nema-
tode infection, and allergic disorders. In support of
this, we previously showed that the number of AR-
expressing mast cells is increased in bronchial mu-
cosa from patients with asthma.3 In addition, AR lev-
els are increased in the sputum from asthmatic pa-
tients.9 However, in the present study, we showed
that even AR-deficient mice similarly developed Th2
cytokine- and mast cell-mediated airway inflammation
in response to OVA. That is, OVA-induced airway in-
flammation accompanied by eosinophilia, OVA-
specific IgG1 and IgE production, and IL-4 and eo-
taxin production was equivalently observed even in
AR-deficient mice. These observations indicate that
AR is not essential for OVA induction of Th2- and
mast cell-mediated airway inflammation. However,
the precise role of AR in the pathogenesis of allergic
asthma may not be fully explained by the animal
model used in our study, in which treatment with
steroids can result in attenuation of acute airway in-
flammation. Accordingly, we originally identified AR
as an upregulated gene in IgE-stimulated human
mast cells even in the presence of glucocorticoids.3
Role of Amphiregulin in Murine Asthma
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These observations suggest that AR may be involved
in the pathogenesis of steroid-resistant chronic
asthma associated with airway remodeling rather
than the pathogenesis of steroid-responsive acute
asthma. Therefore, the role of AR in the pathogenesis
of chronic airway inflammation should be investi-
gated by using AR-deficient mice in a future study.
In summary, we demonstrated that AR is not es-
sential for induction of acute airway inflammation by
OVA in mice.
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